Table 1 Missense and high confidence (HC) loss-of-function (LoF) variants identified in KOVA 2 that are pathogenic or likely pathogenic in ClinVar but not found in gnomAD.

From: A database of 5305 healthy Korean individuals reveals genetic and clinical implications for an East Asian population

Variant class

Locus (hg38)

Base change

AC

AN

AF

Carrier type*

Gene symbol

pLI

ClinVar**

Dominant or Recessive***

ClinVar condition

LoF (HC)

chr3:128481942

CG > C

1

12,234

0.8 × 10−4

C

GATA2

0.98

P

D

Lymphedema, primary, with myelodysplasia; GATA2 deficiency with susceptibility to MDS/AML

chr3:41236467

CAG > C

1

12,148

0.8 × 10−4

V

CTNNB1

1.00

P

D

Mental retardation, autosomal dominant 19; Inborn genetic diseases

chr6:79026060

A > C

1

12,150

0.8 × 10−4

P

PHIP

1.00

P

D

Developmental delay, intellectual disability, obesity, and dysmorphic features

chr7:128846444

C > T

1

12,136

0.8 × 10−4

C

FLNC

1.00

P

D

Myofibrillar myopathy, filamin C-related; Myopathy, distal, 4; Cardiomyopathy, familial hypertrophic, 26; Dilated cardiomyopathy, dominant

chr9:95458142

G > T

1

12,120

0.8 × 10−4

V

PTCH1

1.00

P

D

Gorlin syndrome

chr12:868379

C > T

1

12,134

0.8 × 10−4

C

WNK1

1.00

P

D/R

Hereditary sensory and autonomic neuropathy type IIA

chrX:40064351

G > A

1

12,224

0.8 × 10−4

C

BCOR

1.00

P

D

Oculofaciocardiodental syndrome

Missense

chr1:42927147

C > T

1

12,152

0.8 × 10−4

C

SLC2A1

0.99

LP

D/R

Not provided

chr2:108753474

A > G

1

9310

1.1 × 10−4

C

RANBP2

1.00

P

D

Encephalopathy, acute, infection-induced, 3, susceptibility to

chr3:123296110

G > A

1

12,122

0.8 × 10−4

P

ADCY5

0.99

LP

D/R

Inborn genetic diseases

chr3:128483925

C > T

1

12,238

0.8 × 10−4

P

GATA2

0.98

P

D

Lymphedema, primary, with myelodysplasia; GATA2 deficiency with susceptibility to MDS/AML

chr5:128395182

C > T

1

12,160

0.8 × 10−4

P

FBN2

1.00

C

D

Congenital contractural arachnodactyly

chr5:138570987

T > C

3

10,530

2.8 × 10−4

P, V

HSPA9

0.97

P

D/R

Even-plus syndrome

chr6:157206668

C > T

1

12,144

0.8 × 10−4

V

ARID1B

1.00

LP

D

Coffin-Siris syndrome 1

chr6:3154909

C > T

1

12,116

0.8 × 10−4

V

TUBB2A

0.94

P/LP

D

Cortical dysplasia, complex, with other brain malformations 5

chr7:150952508

G > A

1

12,128

0.8 × 10−4

C

KCNH2

0.99

LP

D

Arrhythmia; Long QT syndrome 2; Congenital long QT syndrome

chr7:5528486

G > C

1

12,126

0.8 × 10−4

V

ACTB

0.99

LP

D

Not provided

chr9:130872896

C > T

1

12,244

0.8 × 10−4

C

ABL1

1.00

P/LP

D

Chronic myelogenous leukemia, BCR-ABL1-positive; Lymphoblastic leukemia, acute, with lymphomatous features; Leukemia, Philadelphia chromosome-positive, resistant to imatinib

chr9:132328351

A > G

1

12,152

0.8 × 10−4

P

SETX

0.96

P

D/R

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2

chr11:119089747

G > A

1

12,144

0.8 × 10−4

V

HMBS

0.95

P

D

Acute intermittent porphyria

chr11:119092785

G > A

1

12,138

0.8 × 10−4

V

HMBS

0.95

LP

D

Not provided

chr12:47978736

G > A

8

10,014

8.0 × 10−4

C, P, V

COL2A1

1.00

LP

D

Spondyloepiphyseal dysplasia, Namaqualand type

chr15:48470646

C > T

1

12,140

0.8 × 10−4

P

FBN1

1.00

LP

D

Not provided

chr16:9840706

G > A

1

12,148

0.8 × 10−4

V

GRIN2A

1.00

P/LP

D

Epilepsy, focal, with speech disorder and with or without mental retardation;

chr18:44951948

G > A

1

12,250

0.8 × 10−4

C

SETBP1

1.00

P

D

Chronic myelogenous leukemia, BCR-ABL1 positive; Schinzel-Giedion syndrome

  1. *C: normal sample of a cancer patient, P: parent of a rare disease patient, V: healthy volunteer.
  2. **P: pathogenic, LP: likely pathogenic.
  3. ***D: dominant, R: recessive, D/R: observed in both patterns.